Detalles de la búsqueda
1.
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 849-56, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686957
2.
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 857-65, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686960
3.
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40.
Ann Surg Oncol
; 24(7): 1853-1860, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27864694
4.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
Lancet Oncol
; 16(9): 1037-1048, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26272770
5.
Bevacizumab added to neoadjuvant chemotherapy for breast cancer.
N Engl J Med
; 366(4): 310-20, 2012 Jan 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-22276821
6.
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group study, N0775.
Cancer
; 119(3): 586-92, 2013 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22915053
7.
Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
J Clin Oncol
; 41(29): 4643-4651, 2023 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37478389
8.
Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB).
Support Care Cancer
; 19(10): 1601-7, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20820817
9.
Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5.
Clin Breast Cancer
; 17(1): 48-54.e3, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693116
10.
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2.
J Clin Oncol
; 35(35): 3942-3948, 2017 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29072977
11.
A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.
Cancer Chemother Pharmacol
; 56(1): 39-45, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15791454
12.
Cediranib (AZD2171) in patients with advanced hepatocellular carcinoma: a phase II North Central Cancer Treatment Group Clinical Trial.
Am J Clin Oncol
; 35(4): 329-33, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21422991
13.
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer.
J Clin Oncol
; 30(31): 3792-9, 2012 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22987084
14.
Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB).
Cancer
; 113(4): 847-53, 2008 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18543329
15.
Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3.
Cancer
; 112(12): 2802-8, 2008 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18428211
16.
Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence.
J Clin Oncol
; 25(15): 2093-9, 2007 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17513815
17.
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
J Thorac Oncol
; 1(6): 537-44, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17409914
18.
A Phase II trial of epothilone B analogue BMS-247550 (NSC #710428) ixabepilone, in patients with advanced pancreas cancer: a Southwest Oncology Group study.
Invest New Drugs
; 24(6): 515-20, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16699973
Resultados
1 -
18
de 18
1
Próxima >
>>